These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11821024)

  • 1. Tolerance to the neurotoxic effects of methamphetamine in young rats.
    Riddle EL; Kokoshka JM; Wilkins DG; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2002 Jan; 435(2-3):181-5. PubMed ID: 11821024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity.
    Friend DM; Keefe KA
    Neurosci Lett; 2013 Oct; 555():243-7. PubMed ID: 23994061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.
    Frey K; Kilbourn M; Robinson T
    Eur J Pharmacol; 1997 Sep; 334(2-3):273-9. PubMed ID: 9369358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic stress augments the long-term and acute effects of methamphetamine.
    Matuszewich L; Yamamoto BK
    Neuroscience; 2004; 124(3):637-46. PubMed ID: 14980734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity.
    Dluzen DE; McDermott JL; Darvesh AS
    Neuroscience; 2010 Jun; 167(4):985-93. PubMed ID: 20211701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats.
    Gehrke BJ; Harrod SB; Cass WA; Bardo MT
    Psychopharmacology (Berl); 2003 Mar; 166(3):249-57. PubMed ID: 12589519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.
    Kaushal N; Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):960-71. PubMed ID: 22921523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
    Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
    Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
    McConnell SE; O'Banion MK; Cory-Slechta DA; Olschowka JA; Opanashuk LA
    Neurotoxicology; 2015 Sep; 50():131-41. PubMed ID: 26283213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
    Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine.
    Johnson-Davis KL; Truong JG; Fleckenstein AE; Wilkins DG
    J Pharmacol Exp Ther; 2004 May; 309(2):578-86. PubMed ID: 14747615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia.
    Tata DA; Raudensky J; Yamamoto BK
    Eur J Neurosci; 2007 Aug; 26(3):739-48. PubMed ID: 17686046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum.
    Howard CD; Keefe KA; Garris PA; Daberkow DP
    J Neurochem; 2011 Aug; 118(4):668-76. PubMed ID: 21668447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation.
    Howard CD; Pastuzyn ED; Barker-Haliski ML; Garris PA; Keefe KA
    J Neurochem; 2013 May; 125(4):555-65. PubMed ID: 23480199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity.
    Stephans S; Yamamoto B
    Neuroscience; 1996 Jun; 72(3):593-600. PubMed ID: 8861054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine.
    Baldwin HA; Colado MI; Murray TK; De Souza RJ; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):590-6. PubMed ID: 8467354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
    Ramkissoon A; Wells PG
    Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial reactivity in resistance to methamphetamine-induced neurotoxicity.
    Friend DM; Keefe KA
    J Neurochem; 2013 May; 125(4):566-74. PubMed ID: 23414433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
    Chapman DE; Hanson GR; Kesner RP; Keefe KA
    J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.